Evotec (OTCMKTS:EVTCY) Stock Price Passes Below 50 Day Moving Average - Here's Why

Key Points

• Evotec SE shares fell below their 50-day moving average of $4.08, trading as low as $3.75 during recent sessions.
• The company has a market capitalization of $1.24 billion and a P/E ratio of 9.15.
• Evotec operates primarily in drug discovery, offering fee-for-service solutions through its EVT Execute and EVT Innovate segments.

Evotec SE (OTCMKTS:EVTCY - ) shares passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $4.08 and traded as low as $3.75. Evotec shares last traded at $3.75, with a volume of 64,313 shares traded.

Evotec Price Performance

The firm's 50-day moving average is $4.08 and its two-hundred day moving average is $3.99. The company has a market cap of $1.24 billion, a P/E ratio of 9.15 and a beta of 0.98. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.